Joensuu H - Search Results

1

Effects of capecitabine as part of neo-/adjuvant chemotherapy - A meta-analysis of individual breast cancer patient data from 13 randomised trials including 15,993 patients.

van Mackelenbergh MT, Seither F, Möbus V, O'Shaughnessy J, Martin M, Joensuu H, Untch M, Nitz U, Steger GG, Miralles JJ, Barrios CH, Toi M, Bear HD, Muss H, Reimer T, Nekljudova V, Loibl S. van Mackelenbergh MT, et al. Among authors: joensuu h. Eur J Cancer. 2022 May;166:185-201. doi: 10.1016/j.ejca.2022.02.003. Epub 2022 Mar 16. Eur J Cancer. 2022. PMID: 35305453

2

Factors predicting late mortality from breast cancer.

Toikkanen SP, Kujari HP, Joensuu H. Toikkanen SP, et al. Among authors: joensuu h. Eur J Cancer. 1991;27(5):586-91. doi: 10.1016/0277-5379(91)90224-2. Eur J Cancer. 1991. PMID: 1828967

3

Delayed diagnosis and large size of breast cancer after a false negative mammogram.

Joensuu H, Asola R, Holli K, Kumpulainen E, Nikkanen V, Parvinen LM. Joensuu H, et al. Eur J Cancer. 1994;30A(9):1299-302. doi: 10.1016/0959-8049(94)90177-5. Eur J Cancer. 1994. PMID: 7999417

4

Autologous stem cell transplantation in breast cancer.

Joensuu H. Joensuu H. Ann Med. 1996 Apr;28(2):145-9. doi: 10.3109/07853899609092939. Ann Med. 1996. PMID: 8732643 Free article. Review.

5

Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.

Joensuu H, Holli K, Heikkinen M, Suonio E, Aro AR, Hietanen P, Huovinen R. Joensuu H, et al. J Clin Oncol. 1998 Dec;16(12):3720-30. doi: 10.1200/JCO.1998.16.12.3720. J Clin Oncol. 1998. PMID: 9850014 Clinical Trial.

6

Late mortality from pT1N0M0 breast carcinoma.

Joensuu H, Pylkkänen L, Toikkanen S. Joensuu H, et al. Cancer. 1999 May 15;85(10):2183-9. doi: 10.1002/(sici)1097-0142(19990515)85:10<2183::aid-cncr12>3.0.co;2-k. Cancer. 1999. PMID: 10326696

7

Leucocyte nadir as a marker for chemotherapy efficacy in node-positive breast cancer treated with adjuvant CMF.

Poikonen P, Saarto T, Lundin J, Joensuu H, Blomqvist C. Poikonen P, et al. Among authors: joensuu h. Br J Cancer. 1999 Aug;80(11):1763-6. doi: 10.1038/sj.bjc.6690594. Br J Cancer. 1999. PMID: 10468293 Free PMC article. Clinical Trial.

8

Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?

Helintö M, Blomqvist C, Heikkilä P, Joensuu H. Helintö M, et al. Among authors: joensuu h. Radiother Oncol. 1999 Sep;52(3):213-7. doi: 10.1016/s0167-8140(99)00099-7. Radiother Oncol. 1999. PMID: 10580866

9

Subclinical cardiotoxicity following adjuvant dose-escalated FEC, high-dose chemotherapy, or CMF in breast cancer.

Erselcan T, Kairemo KJ, Wiklund TA, Hernberg M, Blomqvist CP, Tenhunen M, Bergh J, Joensuu H. Erselcan T, et al. Among authors: joensuu h. Br J Cancer. 2000 Feb;82(4):777-81. doi: 10.1054/bjoc.1999.0998. Br J Cancer. 2000. PMID: 10732745 Free PMC article. Clinical Trial.

10

Prognostic effect of amenorrhoea and elevated serum gonadotropin levels induced by adjuvant chemotherapy in premenopausal node-positive breast cancer patients.

Poikonen P, Saarto T, Elomaa I, Joensuu H, Blomqvist C. Poikonen P, et al. Among authors: joensuu h. Eur J Cancer. 2000 Jan;36(1):43-8. doi: 10.1016/s0959-8049(99)00225-7. Eur J Cancer. 2000. PMID: 10741293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

622 results

Search Page

Filters